Chemotherapy-induced peripheral neuropathy (CIPN) is increasing with introduction of new and combination cancer pharmacotherapies. This study evaluated associations between clinical and self-report measurements and current perception threshold (CPT), a neuroselective measure of sensory nerve function that may detect asymptomatic CIPN damage.

Griffith, K., Couture, D., Zhu, S., Pandya, N., Johantgen, M., Cavaletti, G., et al. (2013). Evaluation of chemotherapy-induced peripheral neuropathy using current perception threshold and clinical evaluations. SUPPORTIVE CARE IN CANCER, 22(5), 1161-1169 [10.1007/s00520-013-2068-0].

Evaluation of chemotherapy-induced peripheral neuropathy using current perception threshold and clinical evaluations

CAVALETTI, GUIDO ANGELO;
2013

Abstract

Chemotherapy-induced peripheral neuropathy (CIPN) is increasing with introduction of new and combination cancer pharmacotherapies. This study evaluated associations between clinical and self-report measurements and current perception threshold (CPT), a neuroselective measure of sensory nerve function that may detect asymptomatic CIPN damage.
Articolo in rivista - Articolo scientifico
CIPN
English
2013
22
5
1161
1169
none
Griffith, K., Couture, D., Zhu, S., Pandya, N., Johantgen, M., Cavaletti, G., et al. (2013). Evaluation of chemotherapy-induced peripheral neuropathy using current perception threshold and clinical evaluations. SUPPORTIVE CARE IN CANCER, 22(5), 1161-1169 [10.1007/s00520-013-2068-0].
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/51270
Citazioni
  • Scopus 40
  • ???jsp.display-item.citation.isi??? 38
Social impact